跳至主要内容
临床试验/NCT02858245
NCT02858245终止不适用

A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device

Abbott Medical Devices8 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
30
试验地点
8
主要终点
Observational change in daily reported activity levels (counts/min) as assessed by actigraphy, from baseline to 30 days post MitraClip implantation

研究概览

简要总结

A prospective, open-label, and multi-centered feasibility registry.

详细描述

This is a prospective, open-label, and multi-centered feasibility registry (single arm study). Approximately 36 subjects with prohibitive risk degenerative mitral regurgitation (DMR) who receive at least 1 commercial MitraClip will be registered at up to 10 US sites.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must consent to receiving the MitraClip device
  • Subject must consent, be able, and commit to wearing the Actiwatch continuously for approximately 7 months
  • Subject must consent to use of their data from this registry for purposes of exploratory research and publication and presentation

排除标准

  • Subject is not a member of vulnerable population
  • Subject must not have any disabilities that preclude reliable data collection from the Actiwatch, e.g., epilepsy with uncontrolled recurring episodes, serious stage degenerative/disabling disease (e.g. Parkinson's disease), inability to walk or will require walking aids, etc.

结局指标

主要结局

Observational change in daily reported activity levels (counts/min) as assessed by actigraphy, from baseline to 30 days post MitraClip implantation

时间窗: At 30 days

Phillips Actiwatch Spectrum PRO is the device being used to capture the primary outcome measure

次要结局

  • Levels of daily and weekly activity as assessed by actigraphy(At 5 months)
  • Patterns of daily Sleep/Wake by actigraphy(At 6 months)
  • NYHA Functional Class(At 30 days)
  • Mitral Regurgitation severity(At 30 days)
  • Echocardiographic assessment(At 30 days)
  • Distance walked 6 minute walk test (6MWT)(At 30 days)
  • Health-related quality of life (QoL)(At 30 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验